Email
PrintBioscience
Dating back at least to the start of the Plough Chemical Company in the early twentieth century and Abe Plough’s first product, Plough’s Antiseptic Healing Oil, the bioscience industry has been alive and well in Memphis. The Plough company turned into a giant and was joined by the likes of Richards Medical and the pioneering medicine of Neuton S. Stern, Willis C. Campbell, and John J. Shea Jr. The year 1962 saw another big bang, when St. Jude Children’s Research Hospital was founded. Today, the tradition of world-class bioscience lives on in the Bluff City — home to orthopedic titans, pharmaceutical marvels, and sci-fi-sounding technologies. The future is today.
JAMES BEATY
Pediatric Orthopaedic Surgeon, Campbell Clinic Orthopaedics. M.D., UT-Memphis. Former Chief of Staff, Campbell Clinic. President, American Academy of Orthopaedic Surgeons, Pediatric Orthopaedic Society of North America, Mid-America Orthopaedic Association, and American Board of Orthopaedic Surgery. Board certified, American Board of Orthopaedic Surgery. Board Member, Campbell Foundation. Director, Pediatric Orthopaedic Fellowship, UT-Campbell Clinic.
JOSEPH DEVIVO
President, Smith & Nephew Orthopaedics. B.S., Marketing and Management, University of Richmond. Former President and CEO, RITA Medical systems and Computer Motion, Inc. Former Vice President and General Manager, Sutures Division; Senior Director of Global Marketing; and Director of Product Development, United States Surgical. Chairman, Greater Memphis Chamber. Member, Memphis Tomorrow. Co-Chair, Memphis Fast Forward. Board Member, Advanced Medical Technology Association.
STEVEN FITZPATRICK
President, Accredo Health, Inc., and Accredo Health Group, Inc. B.S., Finance, Indiana University; Master’s, Marketing, Kellogg School of Management at Northwestern University. Named to position in 2008. Formerly COO, Accredo Health Group. Has held senior management positions with Abbott Laboratories, Block Medical, and PharmaThera, Inc. Certified Public Accountant and Certified Management Accountant. Board Member, Memphis Tomorrow and Ballet Memphis.
KEVIN FOLEY
Director, Complex Spine Surgery, Semmes-Murphey Institute. Director, Spine Fellowship Program, UT Department of Neurosurgery. Professor of Neurosurgery, University of Tennessee Health Science Center. Medical Director and Chairman, Medical Education & Research Institute. M.D., UCLA. Member, AOA Honor Medical Society. Fellow, American College of Surgeons. Member, American Association of Neurological Surgeons, Cervical Spine Research Society, and American Academy of Neurological Surgery.
FRANK A. MCGREW III
Director of Cardiovascular Research and Clinical Cardiologist, The Stern Cardiovascular Center. M.D., Case Western Reserve University. Scientific Project Officer, National Heart, Lung, and Blood Institute. Certified in Internal Medicine and Cardiovascular Disease, American Board of Internal Medicine. Former Governor, American College of Cardiology for Tennessee. Member, Joint Civilian Orientation Committee of the Department of Defense and Duke University Clinical Cardiology Studies Board.
DUANE D. MILLER
Chairman and Professor, Department of Pharmaceutical Sciences, University of Tennessee Health Science Center. Ph.D., Medicinal Chemistry, University of Washington. Inducted into Medicinal Chemistry Hall of Fame, American Chemical Society. Received Volwiler Research Achievement Award. Member, American Chemical Society, American Association of Pharmaceutical Scientists, and American Association for the Advancement of Science.
MARY V. RELLING
Chair, Pharmaceutical Department, St. Jude Children’s Research Hospital. Pharm.D. degree, University of Utah. Elected to Institute of Medicine of the National Academy of Sciences. Awarded Pediatric Cancer Award from American Society of Clinical Oncology and Team Science Prize from American Association of Cancer Research. Part of NIH-funded Pharmacogenomics Research Network. Member, Acute Lymphoblastic Leukemia Committee, Children’s Oncology Group.
MITCHELL STEINER
Co-founder and CEO, GTx. B.A., Molecular Biology, Vanderbilt University; M.D., University of Tennessee; surgical and urological training, The Johns Hopkins Hospital. Founded company in 1997. Vice Chairman, GTx Board. Former Chairman and Professor of Urology, Director of Urologic Oncology and Research, and Chair of Excellence in Urologic Oncology, University of Tennessee. Oversees all of GTx’s product development efforts and its strategies.
GARY STEVENSON
Managing Partner and Co-founder, MB Venture Partners, LLC. B.S., Accounting, University of Missouri; M.B.A., Kellogg School of Business at Northwestern University. Certified Public Accountant and Chartered Financial Analyst. Invests in medical-device and biotech companies. Participated in financing GTx, BioMimetic Therapeutics, Inc., and Protein Discoveries Inc. Board Member, BioSET and Spinal Restoration. Board Member, InMotion Orthopaedic Research Center.
KEN WOODY
President, Innova Memphis. Innova invests and mentors early-stage medical-device companies, biosciences, and technology companies. Has six equity investments, one convertible loan, and four portfolio company board seats. Former U.S. Army Infantry Captain. Former Vice President, General Electric and Johnson & Johnson. Moved to Memphis in 2004 as Senior Vice President, Smith & Nephew Orthopaedics. Board member, arGentis, ExtraOrtho, Cagenix, Vaxent, FedEx Institute of Technology, and LifeScience Tennessee.
